For: | Tabatabaei SA, Amini M, Haydar AA, Soleimani M, Cheraqpour K, Shahriari M, Hassanian-Moghaddam H, Zamani N, Akbari MR. Outbreak of methanol-induced optic neuropathy in early COVID-19 era; effectiveness of erythropoietin and methylprednisolone therapy. World J Clin Cases 2023; 11(15): 3502-3510 [PMID: 37383889 DOI: 10.12998/wjcc.v11.i15.3502] |
---|---|
URL: | https://www.wjgnet.com/2220-3141/full/v11/i15/3502.htm |
Number | Citing Articles |
1 |
Neda Feizi, Mahsa Mohamadzadeh-Nabiei, Hadi Vahedi, Shadi Farabi Maleki, Ali Jafarizadeh. Therapeutic role of erythropoietin in methanol induced optic neuropathy: a systematic review. DARU Journal of Pharmaceutical Sciences 2024; 33(1) doi: 10.1007/s40199-024-00551-w
|
2 |
Nooran O. Badeeb, Shaima Alharazi, Asmaa Mohammedsaleh, Hasan Hijazi, Nihal M. Sadaga, Manal Hadrawi. Erythropoietin for the Treatment of Methanol Toxic Optic Neuropathy: Does It Really Work? A Case Series. Neuro-Ophthalmology 2024; : 1 doi: 10.1080/01658107.2024.2391436
|
3 |
Navid Sobhi, Mirsaeed Abdollahi, Ali Arman, Ata Mahmoodpoor, Ali Jafarizadeh. Methanol Induced Optic Neuropathy: Molecular Mysteries, Public Health Perspective, Clinical Insights and Treatment Strategies. Seminars in Ophthalmology 2025; 40(1): 18 doi: 10.1080/08820538.2024.2358310
|